Jorge A Belardi1, Mariano Albertal1
1Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Overlapping bioresorbable scaffolds (BRS) may reduce long-term risks compared to permanent ones. The GHOST-EU registry found similar short-term risks, but longer studies are needed to confirm BRS safety.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: